IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Current Drug Discovery Technologies

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

1.72

h-Index

2024-2025

 52

Rank

2024-2025

 13925

SJR

2024-2025

 0.394

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Current Drug Discovery Technologies
Abbreviation Curr. Drug Discov. Technol.
Publication Type Journal
Subject Area, Categories, Scope Drug Discovery (Q3)
h-index 52
Overall Rank/Ranking 13925
SCImago Journal Rank (SJR) 0.394
Impact Score 1.72
Publisher Bentham Science Publishers
Country United Arab Emirates
ISSN 15701638, 18756220
Best Quartile Q3
Coverage History 2004-2025




About Current Drug Discovery Technologies


Current Drug Discovery Technologies is a journal covering the technologies/fields/categories related to Drug Discovery (Q3). It is published by Bentham Science Publishers. The overall rank of Current Drug Discovery Technologies is 13925. According to SCImago Journal Rank (SJR), this journal is ranked 0.394. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 52. The best quartile for this journal is Q3.

The ISSN of Current Drug Discovery Technologies journal is 15701638, 18756220. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Drug Discovery Technologies is cited by a total of 303 articles during the last 3 years (Preceding 2024).


Current Drug Discovery Technologies Impact IF 2024-2025


The Impact IF 2024 of Current Drug Discovery Technologies is 1.72, which is computed in 2025 as per its definition. Current Drug Discovery Technologies IF is decreased by a factor of 0.1 and approximate percentage change is -5.49% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Current Drug Discovery Technologies Impact IF 2025 Prediction


Impact IF 2024 of Current Drug Discovery Technologies is 1.72. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of Current Drug Discovery Technologies. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 1.72
2023 1.82
2022 1.68
2021 1.60
2020 1.74
2019 1.29
2018 1.17
2017 1.59
2016 1.65
2015 1.75
2014 1.64

Current Drug Discovery Technologies h-index


  Table Setting

Current Drug Discovery Technologies has an h-index of 52. It means 52 articles of this journal have more than 52 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Current Drug Discovery Technologies ISSN


The ISSN of Current Drug Discovery Technologies is 15701638, 18756220. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Current Drug Discovery Technologies Rank and SCImago Journal Rank (SJR)


The overall rank of Current Drug Discovery Technologies is 13925. According to SCImago Journal Rank (SJR), this journal is ranked 0.394. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Current Drug Discovery Technologies by Year


Year SJR
2025/2026 Coming Soon
2024 0.394
2023 0.319
2022 0.329
2021 0.301
2020 0.319
2019 0.297
2018 0.397
2017 0.449
2016 0.496
2015 0.473
2014 0.668

Ranking of Current Drug Discovery Technologies by Year


Year Ranking
2025/2026 Coming Soon
2024 13925
2023 15151
2022 14246
2021 14747
2020 14215
2019 14486
2018 11366
2017 10015
2016 9337
2015 9630
2014 6985

Current Drug Discovery Technologies Publisher


Table Setting

Current Drug Discovery Technologies is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2004-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Current Drug Discovery Technologies is Curr. Drug Discov. Technol.. This abbreviation ('Curr. Drug Discov. Technol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Current Drug Discovery Technologies


If your research field is/are related to Drug Discovery (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Current Drug Discovery Technologies?

Current Drug Discovery Technologies latest impact IF is 1.72. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 1.82 (2023) and 1.17 (2018), respectively, in the last 11 years. Moreover, its average IS is 1.6 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Current Drug Discovery Technologies?

The Current Drug Discovery Technologies has an SJR (SCImago Journal Rank) of 0.394, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.668 in 2014 and the lowest being 0.297 in 2019. Furthermore, the average SJR of the Current Drug Discovery Technologies over the previous 11-year period stands at 1.6.


What's the latest h-index of the Current Drug Discovery Technologies?

The latest h-index of the Current Drug Discovery Technologies is 52.


Who's the publisher of the Current Drug Discovery Technologies?

The Current Drug Discovery Technologies is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.


What's the current ranking of the Current Drug Discovery Technologies?

The Current Drug Discovery Technologies is currently ranked 13925 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 6985 in 2014 and its lowest position of 15151 in 2023.


What's the abbreviation or short name for the Current Drug Discovery Technologies?

The standard ISO4 abbreviation for the Current Drug Discovery Technologies is Curr. Drug Discov. Technol..


Is the "Current Drug Discovery Technologies" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Current Drug Discovery Technologies is classified as a journal that the Bentham Science Publishers publishes.


What's the scope or major areas of the Current Drug Discovery Technologies?

The Current Drug Discovery Technologies encompasses the following areas:

  • Drug Discovery

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Current Drug Discovery Technologies?

The Current Drug Discovery Technologies is assigned the following International Standard Serial Numbers (ISSN): 15701638, 18756220.


What's the best quartile of the Current Drug Discovery Technologies?

The best quartile for the Current Drug Discovery Technologies is Q3 (2024).


What's the coverage history of the Current Drug Discovery Technologies?

The Current Drug Discovery Technologies coverage history can be summarized as follows: 2004-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 9811 Vilnius Gediminas Technical University 55 2.84
Zeitschrift fur Germanistische Linguistik journal 27452 Walter de Gruyter GmbH 17 0.29
Historia journal 22470 Universidade Estadual Paulista 9 0.16
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division conference and proceedings 17477 16 0.00
Qualitative Research journal 1300 SAGE Publications Ltd 101 6.77
Materials Research journal 15597 Universidade Federal de Sao Carlos 75 1.40
Journal of Education and Work journal 8987 Brill Academic Publishers 47 2.08
International Journal of Research and Method in Education journal 6367 Taylor and Francis Ltd. 41 3.31
Biological Procedures Online journal 5232 BioMed Central Ltd 51 4.00
Journal des Professionnels de l'Enfance journal 30098 TPMA 2 0.00

Check complete list




Year wise Impact Score (IS) of Current Drug Discovery Technologies

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 1.72
2023 1.82
2022 1.68
2021 1.60
2020 1.74
2019 1.29
2018 1.17
2017 1.59
2016 1.65
2015 1.75
2014 1.64



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Protein and Cell
Oxford University Press | United Kingdom

Molecular Therapy
Cell Press | United States

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Ltd | United Kingdom

MedComm
John Wiley and Sons Inc | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Archives of Pharmacal Research
Pharmaceutical Society of Korea | South Korea

See All